top of page

April 2026: Healthcare M&A Snapshot

  • 1 hour ago
  • 2 min read
A summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in April 2026

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in April 2026 below.



Notable Sector Deals: April 2026


MBO of Medicare Insourcing Services backed by Bay Tree


  • Bay Tree Private Equity has invested in Medicare Insourcing Services, a provider of clinical insourcing services to NHS Trusts

  • Founded in 2018, Medicare supports NHS Trusts with additional clinical capacity across diagnostic imaging

  • The investment will support the next phase of growth for the business, with experienced healthcare executive Stephen Collier joining as Chair

  • Medicare has supported more than 60 NHS Trusts and over 3 million patients since launch

  • The deal follows previous transactions in the clinical insourcing sector involving Medicare, 18 Week Support, Remedy and HBS UK


Acquisition of St Matthews Healthcare by CGEN Care


  • CGEN Care Group has acquired St Matthews Healthcare, a specialist provider of high dependency care and rehabilitation services

  • St Matthews operates 10 sites across the Midlands and South of England, including hospitals and specialist care homes

  • The business supports patients with complex mental health conditions and other high acuity care needs across secure and step-down settings

  • The acquisition expands CGEN Care Group’s UK healthcare portfolio following its acquisition of Stow Healthcare in 2025

  • The deal highlights continued investor appetite for specialist care providers operating in high acuity and mental health settings


Acquisition of Complesso by Eden Futures


  • Sovereign-backed Eden Futures has acquired Complesso, a specialist provider of supported living services for adults with complex needs

  • Founded in 2015, Complesso employs almost 500 staff who provide comprehensive support to individuals in their own homes

  • Eden provides supported living services for people with learning or physical disabilities, acquired brain injuries, autism, or mental health conditions

  • The acquisition strengthens Eden’s presence in the West Midlands and expands its supported living service offering

  • The deal forms part of Eden Futures’ ongoing buy-and-build strategy under Sovereign’s ownership


FourCentric’s acquisition of Clarity Consulting Associates


  • FourCentric has acquired Clarity Consulting Associates, a specialist healthcare transformation consultancy

  • Founded in 2015, Clarity supports NHS organisations with transformation, operational improvement and programme delivery services

  • The acquisition strengthens FourCentric’s advisory and transformation capabilities across the UK healthcare sector

  • Clarity will continue to operate under its existing leadership team following the transaction

  • The deal forms part of FourCentric’s ongoing growth strategy under Ansor’s ownership


Healthcare Market Activity: April 2026


Private Equity Activity


Sub-sector

Target

Acquirer / Investor

Exiting PE

Clinical Services

Medicare

Insourcing Services

Bay Tree

Private Equity

N/A

Consulting

Clarity Consulting Associates

FourCentric

(Ansor)

N/A

Medical Equipment

Eakin Surgical

Vernacare

(HIG)

N/A

Medical Equipment

Veenak Veterinary Supplies

Pharmacy2U

(G Square)

N/A

Pharma*

Animalcare Group

Charterhouse Capital

N/A

Pharma Services

Visible Analytics

Newmarket

(Baird)

N/A

Specialist Care

Complesso

Eden Futures (Sovereign)

N/A

Specialist Care

St Matthews Healthcare

CGEN Care

N/A

*Deal announced but yet to complete


Venture Capital Activity


Target

Description

Lead Investor

Investment

Alesi Surgical

Surgical technology

IW Capital

£7m

Auryx

AI-powered health monitoring through earbuds

Celero Ventures

$2m

Calibre

Personalised health intelligence

Amino Collective

£2.5m

Entelo Bio

Human data-to-drug platform

Ananda Impact Ventures

$4m

Plaquetec

Intracoronary liquid biopsy

Existing investors

$5m


 
 
 

Comments


Eclipse Corporate Finance Limited is a limited company registered in England & Wales (registered number 11791669)

The company is regulated by the Institute of Chartered Accountants of Scotland for a range of investment business activities 

  • LinkedIn
bottom of page